These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 38865961)

  • 21. IL-33/ST2 signalling and crosstalk with FcεRI and TLR4 is targeted by the parasitic worm product, ES-62.
    Ball DH; Al-Riyami L; Harnett W; Harnett MM
    Sci Rep; 2018 Mar; 8(1):4497. PubMed ID: 29540770
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prostaglandin E2 in NSAID-exacerbated respiratory disease: protection against cysteinyl leukotrienes and group 2 innate lymphoid cells.
    Rusznak M; Peebles RS
    Curr Opin Allergy Clin Immunol; 2019 Feb; 19(1):38-45. PubMed ID: 30516547
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Interleukin-33 primes mast cells for activation by IgG immune complexes.
    Kaieda S; Wang JX; Shnayder R; Fishgal N; Hei H; Lee RT; Stevens RL; Nigrovic PA
    PLoS One; 2012; 7(10):e47252. PubMed ID: 23071771
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Aspirin-Exacerbated Respiratory Disease Involves a Cysteinyl Leukotriene-Driven IL-33-Mediated Mast Cell Activation Pathway.
    Liu T; Kanaoka Y; Barrett NA; Feng C; Garofalo D; Lai J; Buchheit K; Bhattacharya N; Laidlaw TM; Katz HR; Boyce JA
    J Immunol; 2015 Oct; 195(8):3537-45. PubMed ID: 26342029
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prostaglandin E2 inhibits mast cell-dependent bronchoconstriction in human small airways through the E prostanoid subtype 2 receptor.
    Säfholm J; Manson ML; Bood J; Delin I; Orre AC; Bergman P; Al-Ameri M; Dahlén SE; Adner M
    J Allergy Clin Immunol; 2015 Nov; 136(5):1232-9.e1. PubMed ID: 25962903
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Molecular mechanisms underlying prostaglandin E2-exacerbated inflammation and immune diseases.
    Tsuge K; Inazumi T; Shimamoto A; Sugimoto Y
    Int Immunol; 2019 Aug; 31(9):597-606. PubMed ID: 30926983
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The interleukin-33 receptor ST2 is important for the development of peripheral airway hyperresponsiveness and inflammation in a house dust mite mouse model of asthma.
    Zoltowska AM; Lei Y; Fuchs B; Rask C; Adner M; Nilsson GP
    Clin Exp Allergy; 2016 Mar; 46(3):479-90. PubMed ID: 26609909
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Innate Immunity Induces the Accumulation of Lung Mast Cells During Influenza Infection.
    Zarnegar B; Westin A; Evangelidou S; Hallgren J
    Front Immunol; 2018; 9():2288. PubMed ID: 30337928
    [TBL] [Abstract][Full Text] [Related]  

  • 29. IL-33/ST2 axis in inflammation and immunopathology.
    Milovanovic M; Volarevic V; Radosavljevic G; Jovanovic I; Pejnovic N; Arsenijevic N; Lukic ML
    Immunol Res; 2012 Apr; 52(1-2):89-99. PubMed ID: 22392053
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prostaglandin E
    Grabauskas G; Wu X; Gao J; Li JY; Turgeon DK; Owyang C
    Gastroenterology; 2020 Jun; 158(8):2195-2207.e6. PubMed ID: 32084424
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Characterization of the EP receptor subtype that mediates the inhibitory effects of prostaglandin E2 on IgE-dependent secretion from human lung mast cells.
    Kay LJ; Gilbert M; Pullen N; Skerratt S; Farrington J; Seward EP; Peachell PT
    Clin Exp Allergy; 2013 Jul; 43(7):741-51. PubMed ID: 23786281
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Anti-inflammatory properties of prostaglandin E2: deletion of microsomal prostaglandin E synthase-1 exacerbates non-immune inflammatory arthritis in mice.
    Frolov A; Yang L; Dong H; Hammock BD; Crofford LJ
    Prostaglandins Leukot Essent Fatty Acids; 2013 Oct; 89(5):351-8. PubMed ID: 24055573
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The inhibitory function of Fc-ST2 depends on cell type; IL-1RAcP and ST2 are necessary but insufficient for IL-33 activity.
    Hong K; Lee Y; Lee S; Hong S; Bae S; Hong J; Choi J; Jhun H; Kwak A; Kim E; Jo S; Kang T; Cho YS; Kim YG; Kim S
    Immunol Res; 2013 May; 56(1):122-30. PubMed ID: 23435764
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Interleukin-33 synergistically enhances immune complex-induced tumor necrosis factor alpha and interleukin-8 production in cultured human synovium-derived mast cells.
    Kashiwakura J; Yanagisawa M; Lee H; Okamura Y; Sasaki-Sakamoto T; Saito S; Tokuhashi Y; Ra C; Okayama Y
    Int Arch Allergy Immunol; 2013; 161 Suppl 2():32-6. PubMed ID: 23711851
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Therapeutic Strategies for Targeting IL-33/ST2 Signalling for the Treatment of Inflammatory Diseases.
    Chen WY; Tsai TH; Yang JL; Li LC
    Cell Physiol Biochem; 2018; 49(1):349-358. PubMed ID: 30138941
    [TBL] [Abstract][Full Text] [Related]  

  • 36. IL-33 is produced by mast cells and regulates IgE-dependent inflammation.
    Hsu CL; Neilsen CV; Bryce PJ
    PLoS One; 2010 Aug; 5(8):e11944. PubMed ID: 20689814
    [TBL] [Abstract][Full Text] [Related]  

  • 37. IL-33/ST2 signalling contributes to carrageenin-induced innate inflammation and inflammatory pain: role of cytokines, endothelin-1 and prostaglandin E2.
    Zarpelon AC; Cunha TM; Alves-Filho JC; Pinto LG; Ferreira SH; McInnes IB; Xu D; Liew FY; Cunha FQ; Verri WA
    Br J Pharmacol; 2013 May; 169(1):90-101. PubMed ID: 23347081
    [TBL] [Abstract][Full Text] [Related]  

  • 38. IL-10 Differentially Promotes Mast Cell Responsiveness to IL-33, Resulting in Enhancement of Type 2 Inflammation and Suppression of Neutrophilia.
    Ranjitkar S; Krajewski D; Garcia C; Tedeschi C; Polukort SH; Rovatti J; Mire M; Blesso CN; Jellison E; Schneider SS; Ryan JJ; Mathias CB
    J Immunol; 2024 May; 212(9):1407-1419. PubMed ID: 38497670
    [TBL] [Abstract][Full Text] [Related]  

  • 39. IL-33-mediated mast cell activation promotes gastric cancer through macrophage mobilization.
    Eissmann MF; Dijkstra C; Jarnicki A; Phesse T; Brunnberg J; Poh AR; Etemadi N; Tsantikos E; Thiem S; Huntington ND; Hibbs ML; Boussioutas A; Grimbaldeston MA; Buchert M; O'Donoghue RJJ; Masson F; Ernst M
    Nat Commun; 2019 Jun; 10(1):2735. PubMed ID: 31227713
    [TBL] [Abstract][Full Text] [Related]  

  • 40. IL-33/ST2 Axis Plays a Protective Effect in
    Kuo CF; Chen WY; Yu HH; Tsai YH; Chang YC; Chang CP; Tsao N
    Int J Mol Sci; 2021 Sep; 22(19):. PubMed ID: 34638904
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.